The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?
Reedijk, J. (1999) · Chemical Reviews · doi:10.1021/cr980422f · Cited by 771
Self-citationNovel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y., & Kataoka, K. (2003) · PubMed · Cited by 710
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
Reedijk, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737293100 · Cited by 617
Self-citationCellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Leamon, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.008 · Cited by 558
Drug-polymer conjugates: potential for improved chemotherapy
Duncan, R. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199206000-00001 · Cited by 444
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Dendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Clinical Perspectives on Platinum Resistance
Giaccone, G. (2000) · Drugs · doi:10.2165/00003495-200059004-00002 · Cited by 364
Katano, K., Kondo, A., Safaei, R., Holzer, A. K., Samimi, G., Mishima, M., Kuo, Y., Rochdi, M., & Howell, S. B. (2002) · PubMed · Cited by 291
Newman, M. S., Colbern, G. T., Working, P. K., Engbers, C., & Amantea, M. A. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050855 · Cited by 275
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Nishiyama, N., Yokoyama, M., Aoyagi, T., Okano, T., Sakurai, Y., & Kataoka, K. (1999) · Langmuir · doi:10.1021/la980572l · Cited by 259
Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal
Cutrona, G., Carpaneto, E. M., Ulivi, M., Roncella, S., Landt, O., Ferrarini, M., & Boffa, L. C. (2000) · Nature Biotechnology · doi:10.1038/73745 · Cited by 233
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies
Aronov, O., Horowitz, A. T., Gabizon, A., & Gibson, D. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025642l · Cited by 198
Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity
Burger, K. N. J., Staffhorst, R. W. H. M., de Vijlder, H. C., Velinova, M. J., Bomans, P. H., Frederik, P. M., & de Kruijff, B. (2002) · Nature Medicine · doi:10.1038/nm0102-81 · Cited by 189
Nishiyama, N., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Pharmaceutical Research · doi:10.1023/a:1010908916184 · Cited by 186
Gianasi, E., Wasil, M., Evagorou, E. G., Keddle, A., Wilson, G., & Duncan, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00030-1 · Cited by 186
Interaction of the oligopeptide antibiotics netropsin and distamycin a with nucleic acids
Zimmer, C., Reinert, K. E., Luck, G., Wähnert, U., Löber, G., & Thrum, H. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90250-6 · Cited by 174
Molecular aspects of resistance to antitumor platinum drugs
Brabec, V., & Kasparkova, J. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00047-x · Cited by 161
Antibody-directed enzyme prodrug therapy (ADEPT): a review
Niculescu-Duvaz, I., & Springer, C. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00032-x · Cited by 154
The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats
Siddik, Z. H., Newell, D. R., Boxall, F. E., & Harrap, K. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90490-4 · Cited by 137
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M. E., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., & Herbst, R. S. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 136
Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts
Boulikas, T. (2004) · Oncology Reports · doi:10.3892/or.12.1.3 · Cited by 134
Katano, K., Safaei, R., Samimi, G., Holzer, A. K., Rochdi, M., & Howell, S. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.466 · Cited by 128
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin
Terwogt, J. M. M., Groenewegen, G., Pluim, D., Maliepaard, M., Tibben, M. M., Huisman, A., Huinink, W. W. T. B., Schot, M. E., Welbank, H., Voest, E. E., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100371 · Cited by 124
Vail, D. M., Kurzman, I. D., Glawe, P., O’Brien, M. G., Chun, R., Garrett, L. D., Obradovich, J. E., Fred, R. M., Khanna, C., Colbern, G. T., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0469-8 · Cited by 91
Syrigos, K. N., & Epenetos, A. A. (1999) · PubMed · Cited by 87
Synthesis of 17β-estradiol platinum(II) complexes: biological evaluation on breast cancer cell lines
Descôteaux, C., Provencher-Mandeville, J., Mathieu, I., Perron, V., Mandal, S. K., Asselin, É., & Bérubé, G. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.011 · Cited by 76
Baruah, H., Rector, C. L., Monnier, S. M., & Bierbach, U. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01107-3 · Cited by 74
Cross-resistance to cisplatin in cells with acquired resistance to copper
Safaei, R., Katano, K., Samimi, G., Naerdemann, W., Stevenson, J. L., Rochdi, M., & Howell, S. B. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0736-3 · Cited by 72
Veal, G. J., Griffin, M. J., Price, E., Parry, A., Dick, G., Little, M., Yule, S. M., Morland, B. J., Estlin, E., Hale, J., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1723 · Cited by 69
The First Solid-Phase Synthesis of a Peptide-Tethered Platinum(II) Complex
Robillard, M. S., Valentijn, A. R. P. M., Meeuwenoord, N. J., MAREL, G. A. V. D., BOOM, J. H. V., & Reedijk, J. (2000) · Angewandte Chemie International Edition · Cited by 67
Self-citationImproved targeting of platinum chemotherapeutics
Lin, X., Zhang, Q., Rice, J. R., Stewart, D. R., Nowotnik, D. P., & Howell, S. B. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.022 · Cited by 56
Aronov, O., Horowitz, A. T., Gabizon, A., et al. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499331 · Cited by 56
Anticancer metal complexes and tumour targeting strategies
Kratz, F., & Schütte, M. T. (1998) · Cancer Journal · Cited by 36
Verschraegen, C. F., Kumagai, S., Davidson, R., Feig, B. W., Mansfield, P. F., Lee, S. J., MacLean, D. S., Hu, W., Khokhar, A. R., & Siddik, Z. H. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0481-3 · Cited by 26
Importance of receptor-mediated endocytosis in peptide delivery and targeting: kinetic aspects
Sato, H., Sugiyama, Y., Tsuji, A., & Horikoshi, I. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00013-0 · Cited by 24
Lee, M., Simpson, J. E., Burns, A. J., Kupchinsky, S., Brooks, N. A., Hartley, J. A., & Kèlland, L. R. (1996) · UCL Discovery (University College London) · Cited by 12
The synthesis and characterization of new triphenylethylene platinum(II) complexes
Bérubé, G., He, Y., Groleau, S., Séné, A., Thérien, H.-M., & Caron, M. (1997) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(97)05514-x · Cited by 11
Cited by
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Wilson, J. J., & Lippard, S. J. (2014) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 630
Advances in Toxicological Research of the Anticancer Drug Cisplatin
Qi, L., Luo, Q., Zhang, Y., Jia, F., Zhao, Y., & Wang, F. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00204 · Cited by 440
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Metadata
- Authors
- Zutphen, S. V., & Reedijk, J.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 249
- Issue
- 24
- Pages
- 2845-2853
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2053861556
- Cited by
- 295
- References
- 45
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.